Insights
“Time to turn words into action” – a response to O’Shaughnessy review
Ee Ching Tan
Following Lord O’Shaughnessy’s new review into commercial clinical trials, Professor Sir Martin Landray has co-authored an article for The Lancet exploring how the UK can deliver on the recommendations outlined in the review.
Public consultation on key global guideline for clinical trials launched
Ee Ching Tan
The Good Clinical Trials Collaborative is organizing community response to ensure new guideline helps trials to be informative, ethical and efficient.
New film reaffirms importance of good trials and good guidance
Ee Ching Tan
The Good Clinical Trials Collaborative’s new film sees experts discuss the importance of high-quality trials in advancing global healthcare and the role of good guidance in influencing change.
Celebrating Clinical Trials Day with new content series, #GoodTrialsGrapevine
Ee Ching Tan
To commemorate Clinical Trials Day this year, we are kicking off a new content series, #GoodTrialsGrapevine, where we invite clinical trials experts and thought leaders to share their perspectives on key themes in clinical research; what makes a good trial and why.
“Fast tracking informative clinical trials: lessons for mental health” – our commentary in Lancet Psychiatry
Ee Ching Tan
Recent policy initiatives have called for clinical trials to be strengthened as a response to future pandemics. We argue that similar efforts must be made to improve the trials landscape for non-communicable diseases, particularly mental health.
Inside Goodtrials Newsletter – February 2023
masteruser
The year ahead will see major initiatives take significant steps in shaping the future of clinical trials globally. From the anticipated public consultation on updated ICH Good Clinical Practice guidance to new World Health Organization (WHO) Guidance on Best Practices for Clinical Trials...
Response to White House review – Emergency Clinical Trials
Ee Ching Tan
The Collaborative responded to a recent call for input from the White House Office for Science & Technology Policy on how the U.S. and the world can mount a better clinical trials response to future health emergencies. Our response makes five recommendations on priority actions.
Endorsement by cardiology leaders
Ee Ching Tan
The Collaborative welcomes the endorsement of our Guidance in the joint opinion by world cardiology leaders European Society of Cardiology, American Heart Association, World Heart Federation and American College of Cardiology about the need for better RCTs in this rapidly changing and increasingly global world.
